Aeterna Zentaris second-quarter revenues decrease to $5.

The comparative decrease in net R&D costs is certainly primarily attributable to the winding down and termination of advancement activities linked to cetrorelix in BPH. Net loss was $4.5 million, or $0.06 per basic and diluted share, june 30 for the three-month period ended, 2010, in comparison to $13.1 million, or $0.24 per simple and diluted share, for the same period in ’09 2009.S. Dollar, offset by the comparative decrease in revenues partly, as discussed above.Kaiser Health Information, an unbiased news service editorially, is an application of the Kaiser Family Foundation, a nonpartisan health care policy research business unaffiliated with Kaiser Permanente.. Acne Scar Removal: Prevention Is Still the Best Cure! Numerous acne scar removal techniques are available for nearly every type and every level of severity of scarring. Nevertheless, it is much better unless you need to use any of these removal methods since many of them could be very expensive plus some procedures can be even painful.